1 (619) 944-9009 ·
[email protected] JOSHUA Y. YANG www.linkedin.com/in/joshuayoungyang www.joshuayang.com BACKGROUND With a background in life sciences technologies development, unmet clinical needs discovery, and biotechnology and healthcare entrepreneurship, Josh invents and commercializes biomedical technologies that he can translate into clinical practice. He also works to identify promising biotech and healthcare innovations and startups for investment opportunities and was named to the Forbes 30 Under 30 Healthcare list in 2021. Currently, he is pursuing a triple MD/PhD/MBA at the Johns Hopkins University School of Medicine Department of Biomedical Engineering and the Stanford University Graduate School of Business, where he was selected as a Siebel Scholar. His startup Nephrosant has raised over $22M in funding to commercialize a low-cost, non-invasive diagnostic assay for kidney injury. EDUCATION Stanford University Graduate School of Business | Stanford, CA 09/201 9 – Present Master of Business Administration, M.B.A. (Expected 2021) Siebel Scholar Johns Hopkins University School of Medicine | Baltimore, MD 08/2016 – 12/2018 Doctor of Medicine, M.D. (On LOA) Doctor of Philosophy in Bioengineering, Ph.D. Sigma Xi Attended fully funded with stipend on the Medical Scientist Training Program Grant University of California, San Francisco | San Francisco, CA 08/2015 – 06/2016 University of California, Berkeley | Berkeley, CA Master of Engineering in Translational Medicine, M.Eng. University of California, San Diego | La Jolla,